Clinical Trials Browser

Phase 2 × Squamous Cell Carcinoma of Head and Neck × ARQ 197 × Clear all

NCT01696955 2018-12-19

Cetuximab With or Without Tivantinib in Treating Patients With Head and Neck Cancer That Is Recurrent, Metastatic, or Cannot Be Removed by Surgery

Phase 2 Completed

81 enrolled 14 charts

Squamous Cell Carcinoma of Head and Neck